<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, the results of this study may provide a basis for studies in other groups of patients with vascular and/or autoimmune diseases. The extensive vascular damage and loss of neovascularisation and vascular regeneration makes SSc a relevant 'model disease' to study new therapeutic regenerative strategies aimed at therapeutic neovascularisation.
 <xref rid="R77" ref-type="bibr">77</xref> If we observe beneficial immunomodulatory effects this may provide a basis for further studies in SSc but also in other autoimmune diseases.
</p>
